Cite
HARVARD Citation
Cho, B. et al. (2018). Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer. Lung cancer. pp. 14-21. [Online].